{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:01:36Z","timestamp":1792641696034,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Reducing neuroinflammatory damage is an effective strategy for treating white-matter damage (WMD) in premature infants. Caffeine can ameliorate hypoxia\u2013ischemia-induced brain WMD; however, its neuroprotective effect and mechanism against hypoxic\u2013ischemic WMD remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We used 3-day-old Sprague\u2013Dawley rats to establish a model of cerebral hypoxia\u2013ischemia-induced brain WMD after unilateral common carotid artery ligation and hypoxia exposure (8% O\n                      <jats:sub>2<\/jats:sub>\n                      \u2009+\u200992% N\n                      <jats:sub>2<\/jats:sub>\n                      ) for 2.5\u2009h. Mechanism experiments were conducted to detect M1\/M2 polarization and activation of microglia and NLRP3 inflammasome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Caffeine inhibited NLRP3 inflammasome activation, reduced microglial Iba-1 activation, inhibited microglia M1 polarization, and promoted microglia M2 polarization by downregulating CD86 and iNOS protein expression, inhibiting the transcription of the proinflammatory TNF-\u03b1 and IL-1\u03b2, upregulating CD206 and Arg-1 expression, and promoting the transcription of the anti-inflammatory factors IL-10 and TGF-\u03b2. Importantly, we found that these caffeine-mediated effects could be reversed after inhibiting A2aR activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Caffeine improved long-term cognitive function in neonatal rats with hypoxic\u2013ischemic WMD via A2aR-mediated inhibition of NLRP3 inflammasome activation, reduction of microglial activation, regulation of the phenotypic polarization of microglia and the release of inflammatory factors, and improvement of myelination development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>The direct protective effect of caffeine on hypoxic\u2013ischemic white-matter damage (WMD) and its mechanism remains unclear. This study elucidated this mechanism using neonatal rats as an animal model of hypoxia\u2013ischemia-induced cerebral WMD.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The findings demonstrated caffeine as a promising therapeutic tool against immature WMD to protect neonatal cognitive function.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>We found that caffeine pretreatment reduced WMD in immature brains via regulation of microglial activation and polarization by adenosine A2a receptor, thereby, providing a scientific basis for future clinical application of caffeine.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-021-01924-6","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T09:02:24Z","timestamp":1645866144000},"page":"1543-1554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Caffeine treatment started before injury reduces hypoxic\u2013ischemic white-matter damage in neonatal rats by regulating phenotypic microglia polarization"],"prefix":"10.1038","volume":"92","author":[{"given":"Liu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xindong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,26]]},"reference":[{"key":"1924_CR1","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1542\/peds.2009-3598","volume":"127","author":"MA Woythaler","year":"2011","unstructured":"Woythaler, M. A., McCormick, M. C. & Smith, V. C. Late preterm infants have worse 24-month neurodevelopmental outcomes than term infants. Pediatrics 127, e622\u2013e629 (2011).","journal-title":"Pediatrics"},{"key":"1924_CR2","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/apa.13880","volume":"106","author":"T Raju","year":"2017","unstructured":"Raju, T., Buist, A. S., Blaisdell, C. J., Moxey-Mims, M. & Saigal, S. Adults born preterm: a review of general health and system-specific outcomes. Acta Paediatr. 106, 1409\u20131437 (2017).","journal-title":"Acta Paediatr."},{"key":"1924_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/dmcn.13297","volume":"59","author":"AJ Spittle","year":"2017","unstructured":"Spittle, A. J. et al. Neurobehaviour at term-equivalent age and neurodevelopmental outcomes at 2 years in infants born moderate-to-late preterm. Dev. Med. Child Neurol. 59, 207\u2013215 (2017).","journal-title":"Dev. Med. Child Neurol."},{"key":"1924_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1055\/s-0035-1571150","volume":"33","author":"G Natarajan","year":"2016","unstructured":"Natarajan, G. & Shankaran, S. Short- and long-term outcomes of moderate and late preterm infants. Am. J. Perinatol. 33, 305\u2013317 (2016).","journal-title":"Am. J. Perinatol."},{"key":"1924_CR5","doi-asserted-by":"publisher","first-page":"e0175438","DOI":"10.1371\/journal.pone.0175438","volume":"12","author":"N Zaghloul","year":"2017","unstructured":"Zaghloul, N., Patel, H. & Ahmed, M. N. A model of periventricular leukomalacia (PVL) in neonate mice with histopathological and neurodevelopmental outcomes mimicking human PVL in neonates. PLoS ONE 12, e0175438 (2017).","journal-title":"PLoS ONE"},{"key":"1924_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1542\/peds.2005-0191","volume":"116","author":"JJ Volpe","year":"2005","unstructured":"Volpe, J. J. Encephalopathy of prematurity includes neuronal abnormalities. Pediatrics 116, 221\u2013225 (2005).","journal-title":"Pediatrics"},{"key":"1924_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.earlhumdev.2004.04.009","volume":"79","author":"O Dammann","year":"2004","unstructured":"Dammann, O. & Leviton, A. Inflammatory brain damage in preterm newborns\u2014dry numbers, wet lab, and causal inferences. Early Hum. Dev. 79, 1\u201315 (2004).","journal-title":"Early Hum. Dev."},{"key":"1924_CR8","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/00004647-200412000-00003","volume":"24","author":"M Hedtj\u00e4rn","year":"2004","unstructured":"Hedtj\u00e4rn, M., Mallard, C. & Hagberg, H. Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J. Cereb. Blood Flow Metab. 24, 1333\u20131351 (2004).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"1924_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1042\/BST20130284","volume":"42","author":"J Van Steenwinckel","year":"2014","unstructured":"Van Steenwinckel, J., Schang, A. L. & Sigaut, S. et al. Brain damage of the preterm infant: new insights into the role of inflammation. Biochem. Soc. Trans. 42, 557\u2013563 (2014).","journal-title":"Biochem. Soc. Trans."},{"key":"1924_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.clp.2018.01.015","volume":"45","author":"CM Novak","year":"2018","unstructured":"Novak, C. M., Ozen, M. & Burd, I. Perinatal brain injury: mechanisms, prevention, and outcomes. Clin. Perinatol. 45, 357\u2013375 (2018).","journal-title":"Clin. Perinatol."},{"key":"1924_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-02038-2","volume":"17","author":"E Sigfridsson","year":"2020","unstructured":"Sigfridsson, E., Marangoni, M., Hardingham, G. E., Horsburgh, K. & Fowler, J. H. Deficiency of Nrf2 exacerbates white matter damage and microglia\/macrophage levels in a mouse model of vascular cognitive impairment. J. Neuroinflammation 17, 367 (2020).","journal-title":"J. Neuroinflammation"},{"key":"1924_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1668-0","volume":"16","author":"SH Su","year":"2019","unstructured":"Su, S. H., Wu, Y. F., Lin, Q., Wang, D. P. & Hai, J. URB597 protects against NLRP3 inflammasome activation by inhibiting autophagy dysfunction in a rat model of chronic cerebral hypoperfusion. J. Neuroinflammation 16, 260 (2019).","journal-title":"J. Neuroinflammation"},{"key":"1924_CR13","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3389\/fimmu.2017.02012","volume":"8","author":"M Gharagozloo","year":"2017","unstructured":"Gharagozloo, M., Gris, K. V., Mahvelati, T., Amrani, A., Lukens, J. R. & Gris, D. NLR-dependent regulation of inflammation in multiple sclerosis. Front. Immunol. 8, 2012 (2017).","journal-title":"Front. Immunol."},{"key":"1924_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/bs.apcsb.2019.08.007","volume":"119","author":"M Olcum","year":"2020","unstructured":"Olcum, M., Tastan, B., Kiser, C., Genc, S. & Genc, K. Microglial NLRP3 inflammasome activation in multiple sclerosis. Adv. Protein Chem. Struct. Biol. 119, 247\u2013308 (2020).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"1924_CR15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fncel.2018.00488","volume":"12","author":"S Bachiller","year":"2018","unstructured":"Bachiller, S. et al. Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response. Front. Cell. Neurosci. 12, 488 (2018).","journal-title":"Front. Cell. Neurosci."},{"key":"1924_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.intimp.2017.08.007","volume":"51","author":"R Aryanpour","year":"2017","unstructured":"Aryanpour, R. et al. Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model. Int. Immunopharmacol. 51, 131\u2013139 (2017).","journal-title":"Int. Immunopharmacol."},{"key":"1924_CR17","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.7150\/thno.27882","volume":"8","author":"C Qin","year":"2018","unstructured":"Qin, C. et al. Microglial TLR4-dependent autophagy induces ischemic white matter damage via STAT1\/6 pathway. Theranostics 8, 5434\u20135451 (2018).","journal-title":"Theranostics"},{"key":"1924_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1488-2","volume":"16","author":"X Chu","year":"2019","unstructured":"Chu, X. et al. Hydrogen-rich saline promotes microglia M2 polarization and complement-mediated synapse loss to restore behavioral deficits following hypoxia-ischemic in neonatal mice via AMPK activation. J. Neuroinflammation 16, 104 (2019).","journal-title":"J. Neuroinflammation"},{"key":"1924_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s12031-019-01454-1","volume":"70","author":"D Zhou","year":"2020","unstructured":"Zhou, D., Ji, L. & Chen, Y. TSPO modulates IL-4-induced microglia\/macrophage M2 polarization via PPAR-\u03b3 pathway. J. Mol. Neurosci. 70, 542\u2013549 (2020).","journal-title":"J. Mol. Neurosci."},{"key":"1924_CR20","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1056\/NEJMoa054065","volume":"354","author":"B Schmidt","year":"2006","unstructured":"Schmidt, B. et al. Caffeine therapy for apnea of prematurity. N. Engl. J. Med. 354, 2112\u20132121 (2006).","journal-title":"N. Engl. J. Med."},{"key":"1924_CR21","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa073679","volume":"357","author":"B Schmidt","year":"2007","unstructured":"Schmidt, B. et al. Long-term effects of caffeine therapy for apnea of prematurity. N. Engl. J. Med. 357, 1893\u20131902 (2007).","journal-title":"N. Engl. J. Med."},{"key":"1924_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.pedneo.2016.10.003","volume":"58","author":"B Shrestha","year":"2017","unstructured":"Shrestha, B. & Jawa, G. Caffeine citrate - is it a silver bullet in neonatology. Pediatr. Neonatol. 58, 391\u2013397 (2017).","journal-title":"Pediatr. Neonatol."},{"key":"1924_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.clp.2016.07.011","volume":"43","author":"NR Dobson","year":"2016","unstructured":"Dobson, N. R. & Patel, R. M. The role of caffeine in noninvasive respiratory support. Clin. Perinatol. 43, 773\u2013782 (2016).","journal-title":"Clin. Perinatol."},{"key":"1924_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/cns.12684","volume":"23","author":"M Kolahdouzan","year":"2017","unstructured":"Kolahdouzan, M. & Hamadeh, M. J. The neuroprotective effects of caffeine in neurodegenerative diseases. CNS Neurosci. Ther. 23, 272\u2013290 (2017).","journal-title":"CNS Neurosci. Ther."},{"key":"1924_CR25","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s11064-018-02710-3","volume":"44","author":"ML Garcez","year":"2019","unstructured":"Garcez, M. L. et al. Caffeine neuroprotection decreases A2A adenosine receptor content in aged mice. Neurochem. Res. 44, 787\u2013795 (2019).","journal-title":"Neurochem. Res."},{"key":"1924_CR26","doi-asserted-by":"crossref","unstructured":"Kumar, V. & Lipshultz, S. E. Caffeine and clinical outcomes in premature neonates. Children 6, 118 (2019).","DOI":"10.3390\/children6110118"},{"key":"1924_CR27","doi-asserted-by":"publisher","first-page":"11718","DOI":"10.1073\/pnas.1931975100","volume":"100","author":"CP Turner","year":"2003","unstructured":"Turner, C. P. et al. A1 adenosine receptors mediate hypoxia-induced ventriculomegaly. Proc. Natl Acad. Sci. USA 100, 11718\u201311722 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1924_CR28","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3109\/14767058.2013.878694","volume":"27","author":"H Kilicdag","year":"2014","unstructured":"Kilicdag, H., Daglioglu, Y. K., Erdogan, S. & Zorludemir, S. Effects of caffeine on neuronal apoptosis in neonatal hypoxic-ischemic brain injury. J. Matern. Fetal Neonatal Med. 27, 1470\u20131475 (2014).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"1924_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijdevneu.2018.02.001","volume":"70","author":"M Potter","year":"2018","unstructured":"Potter, M., Rosenkrantz, T. & Fitch, R. H. Behavioral and neuroanatomical outcomes in a rat model of preterm hypoxic-ischemic brain Injury: effects of caffeine and hypothermia. Int. J. Dev. Neurosci. 70, 46\u201355 (2018).","journal-title":"Int. J. Dev. Neurosci."},{"key":"1924_CR30","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/ana.21008","volume":"60","author":"SA Back","year":"2006","unstructured":"Back, S. A. et al. Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury. Ann. Neurol. 60, 696\u2013705 (2006).","journal-title":"Ann. Neurol."},{"key":"1924_CR31","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/414916a","volume":"414","author":"A Ohta","year":"2001","unstructured":"Ohta, A. & Sitkovsky, M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916\u2013920 (2001).","journal-title":"Nature"},{"key":"1924_CR32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3389\/fneur.2018.00605","volume":"9","author":"M Colella","year":"2018","unstructured":"Colella, M. et al. Modulation of microglial activation by adenosine A2a receptor in animal models of perinatal brain injury. Front. Neurol. 9, 605 (2018).","journal-title":"Front. Neurol."},{"key":"1924_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1471-4159.2011.07178.x","volume":"117","author":"N Rebola","year":"2011","unstructured":"Rebola, N. et al. Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction. J. Neurochem. 117, 100\u2013111 (2011).","journal-title":"J. Neurochem."},{"key":"1924_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1","volume":"55","author":"RC Vannucci","year":"1999","unstructured":"Vannucci, R. C. et al. Rat model of perinatal hypoxic-ischemic brain damage. J. Neurosci. Res. 55, 158\u2013163 (1999).","journal-title":"J. Neurosci. Res."},{"key":"1924_CR35","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.3892\/mmr.2014.3028","volume":"11","author":"T Cheng","year":"2015","unstructured":"Cheng, T., Xue, X. & Fu, J. Effect of OLIG1 on the development of oligodendrocytes and myelination in a neonatal rat PVL model induced by hypoxia-ischemia. Mol. Med. Rep. 11, 2379\u20132386 (2015).","journal-title":"Mol. Med. Rep."},{"key":"1924_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.neuropharm.2018.10.003","volume":"143","author":"E Coppi","year":"2018","unstructured":"Coppi, E. et al. Dexpramipexole enhances hippocampal synaptic plasticity and memory in the rat. Neuropharmacology 143, 306\u2013316 (2018).","journal-title":"Neuropharmacology"},{"key":"1924_CR37","first-page":"5249675","volume":"2019","author":"N Liu","year":"2019","unstructured":"Liu, N., Tong, X., Huang, W., Fu, J. & Xue, X. Synaptic injury in the thalamus accompanies white matter injury in hypoxia\/ischemia-mediated brain injury in neonatal rats. Biomed. Res. Int. 2019, 5249675 (2019).","journal-title":"Biomed. Res. Int."},{"key":"1924_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fncel.2017.00063","volume":"11","author":"L Song","year":"2017","unstructured":"Song, L., Pei, L., Yao, S., Wu, Y. & Shang, Y. NLRP3 inflammasome in neurological diseases, from functions to therapies. Front. Cell. Neurosci. 11, 63 (2017).","journal-title":"Front. Cell. Neurosci."},{"key":"1924_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01842-0","volume":"17","author":"Y Dong","year":"2020","unstructured":"Dong, Y. et al. Stress-induced NLRP3 inflammasome activation negatively regulates fear memory in mice. J. Neuroinflammation 17, 205 (2020).","journal-title":"J. Neuroinflammation"},{"key":"1924_CR40","doi-asserted-by":"publisher","first-page":"113399","DOI":"10.1016\/j.expneurol.2020.113399","volume":"332","author":"DC Ma","year":"2020","unstructured":"Ma, D. C., Zhang, N. N., Zhang, Y. N. & Chen, H. S. Kv1.3 channel blockade alleviates cerebral ischemia\/reperfusion injury by reshaping M1\/M2 phenotypes and compromising the activation of NLRP3 inflammasome in microglia. Exp. Neurol. 332, 113399 (2020).","journal-title":"Exp. Neurol."},{"key":"1924_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fnagi.2020.00153","volume":"12","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Genistein attenuates acute cerebral ischemic damage by inhibiting the NLRP3 inflammasome in reproductively senescent mice. Front. Aging Neurosci. 12, 153 (2020).","journal-title":"Front. Aging Neurosci."},{"key":"1924_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.expneurol.2011.04.021","volume":"230","author":"W Liu","year":"2011","unstructured":"Liu, W., Shen, Y., Plane, J. M., Pleasure, D. E. & Deng, W. Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia. Exp. Neurol. 230, 227\u2013239 (2011).","journal-title":"Exp. Neurol."},{"key":"1924_CR43","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.2353\/ajpath.2009.090051","volume":"175","author":"DJ Webber","year":"2009","unstructured":"Webber, D. J., van Blitterswijk, M. & Chandran, S. Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia. Am. J. Pathol. 175, 2332\u20132342 (2009).","journal-title":"Am. J. Pathol."},{"key":"1924_CR44","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1007\/s12035-020-01867-9","volume":"57","author":"E Di Martino","year":"2020","unstructured":"Di Martino, E. et al. Defining a time window for neuroprotection and glia modulation by caffeine after neonatal hypoxia-ischaemia. Mol. Neurobiol. 57, 2194\u20132205 (2020).","journal-title":"Mol. Neurobiol."},{"key":"1924_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1203\/PDR.0b013e3181e5bc78","volume":"68","author":"CA Julien","year":"2010","unstructured":"Julien, C. A., Joseph, V. & Bairam, A. Caffeine reduces apnea frequency and enhances ventilatory long-term facilitation in rat pups raised in chronic intermittent hypoxia. Pediatr. Res. 68, 105\u2013111 (2010).","journal-title":"Pediatr. Res."},{"key":"1924_CR46","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/apa.14636","volume":"108","author":"J Huvanandana","year":"2019","unstructured":"Huvanandana, J., Thamrin, C., Hinder, M., McEwan, A. & Tracy, M. B. The effect of caffeine loading on cerebral autoregulation in preterm infants. Acta Paediatr. 108, 436\u2013442 (2019).","journal-title":"Acta Paediatr."},{"key":"1924_CR47","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.bbrc.2019.11.003","volume":"521","author":"Y Lv","year":"2020","unstructured":"Lv, Y. et al. The role of microglia mediated pyroptosis in neonatal hypoxic-ischemic brain damage. Biochem. Biophys. Res. Commun. 521, 933\u2013938 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1924_CR48","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11481-012-9347-2","volume":"8","author":"C Kaur","year":"2013","unstructured":"Kaur, C., Rathnasamy, G. & Ling, E. A. Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina. J. Neuroimmune Pharmacol. 8, 66\u201378 (2013).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"1924_CR49","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrneurol.2010.53","volume":"6","author":"W Deng","year":"2010","unstructured":"Deng, W. Neurobiology of injury to the developing brain. Nat. Rev. Neurol. 6, 328\u2013336 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"1924_CR50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrneurol.2015.13","volume":"11","author":"H Hagberg","year":"2015","unstructured":"Hagberg, H. et al. The role of inflammation in perinatal brain injury. Nat. Rev. Neurol. 11, 192\u2013208 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"1924_CR51","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pneurobio.2017.10.006","volume":"159","author":"B Li","year":"2017","unstructured":"Li, B., Concepcion, K., Meng, X. & Zhang, L. Brain-immune interactions in perinatal hypoxic-ischemic brain injury. Prog. Neurobiol. 159, 50\u201368 (2017).","journal-title":"Prog. Neurobiol."},{"key":"1924_CR52","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela, R., McPherson, C. A. & Harry, G. J. Microglial M1\/M2 polarization and metabolic states. Br. J. Pharmacol. 173, 649\u2013665 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"1924_CR53","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1161\/STROKEAHA.117.018505","volume":"48","author":"C Qin","year":"2017","unstructured":"Qin, C. et al. Fingolimod protects against ischemic white matter damage by modulating microglia toward M2 polarization via STAT3 pathway. Stroke 48, 3336\u20133346 (2017).","journal-title":"Stroke"},{"key":"1924_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainresbull.2019.05.016","volume":"150","author":"Z Chen","year":"2019","unstructured":"Chen, Z. et al. Interleukin-33 reduces neuronal damage and white matter injury via selective microglia M2 polarization after intracerebral hemorrhage in rats. Brain Res. Bull. 150, 127\u2013135 (2019).","journal-title":"Brain Res. Bull."},{"key":"1924_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000435858","volume":"25","author":"R Barakat","year":"2016","unstructured":"Barakat, R. & Redzic, Z. The role of activated microglia and resident macrophages in the neurovascular unit during cerebral ischemia: is the jury still out. Med. Princ. Pract. 25, 3\u201314 (2016).","journal-title":"Med. Princ. Pract."},{"key":"1924_CR56","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/cns.13266","volume":"25","author":"J Lee","year":"2019","unstructured":"Lee, J., Hamanaka, G., Lo, E. H. & Arai, K. Heterogeneity of microglia and their differential roles in white matter pathology. CNS Neurosci. Ther. 25, 1290\u20131298 (2019).","journal-title":"CNS Neurosci. Ther."},{"key":"1924_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1282-6","volume":"15","author":"Z Gong","year":"2018","unstructured":"Gong, Z., Pan, J., Shen, Q., Li, M. & Peng, Y. Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia\/reperfusion injury. J. Neuroinflammation 15, 242 (2018).","journal-title":"J. Neuroinflammation"},{"key":"1924_CR58","doi-asserted-by":"crossref","unstructured":"Irrera, N. et al. The role of NLRP3 inflammasome in the pathogenesis of traumatic brain injury. Int. J. Mol. Sci. 21, 6204 (2020).","DOI":"10.3390\/ijms21176204"},{"key":"1924_CR59","doi-asserted-by":"publisher","first-page":"9238290","DOI":"10.1155\/2016\/9238290","volume":"2016","author":"K Zhou","year":"2016","unstructured":"Zhou, K., Shi, L., Wang, Y., Chen, S. & Zhang, J. Recent advances of the NLRP3 inflammasome in central nervous system disorders. J. Immunol. Res. 2016, 9238290 (2016).","journal-title":"J. Immunol. Res."},{"key":"1924_CR60","doi-asserted-by":"publisher","first-page":"582","DOI":"10.2174\/1570159X17666181227170053","volume":"17","author":"Y Luo","year":"2019","unstructured":"Luo, Y., Reis, C. & Chen, S. NLRP3 inflammasome in the pathophysiology of hemorrhagic stroke: a review. Curr. Neuropharmacol. 17, 582\u2013589 (2019).","journal-title":"Curr. Neuropharmacol."},{"key":"1924_CR61","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuroscience.2021.03.025","volume":"463","author":"R Aryanpour","year":"2021","unstructured":"Aryanpour, R. et al. 17\u03b2-estradiol reduces demyelination in cuprizone-fed mice by promoting M2 microglia polarity and regulating NLRP3 inflammasome. Neuroscience 463, 116\u2013127 (2021).","journal-title":"Neuroscience"},{"key":"1924_CR62","doi-asserted-by":"publisher","first-page":"146779","DOI":"10.1016\/j.brainres.2020.146779","volume":"1736","author":"H Matsuyama","year":"2020","unstructured":"Matsuyama, H. et al. Chronic cerebral hypoperfusion activates AIM2 and NLRP3 inflammasome. Brain Res. 1736, 146779 (2020).","journal-title":"Brain Res."},{"key":"1924_CR63","doi-asserted-by":"publisher","first-page":"1552127","DOI":"10.1155\/2021\/1552127","volume":"2021","author":"Y Ran","year":"2021","unstructured":"Ran, Y. et al. Curcumin ameliorates white matter injury after ischemic stroke by inhibiting microglia\/macrophage pyroptosis through NF-\u03baB suppression and NLRP3 inflammasome inhibition. Oxid. Med. Cell. Longev. 2021, 1552127 (2021).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"1924_CR64","doi-asserted-by":"publisher","first-page":"724161","DOI":"10.3389\/fped.2021.724161","volume":"9","author":"L Yang","year":"2021","unstructured":"Yang, L., Yu, X., Zhang, Y., Liu, N., Xue, X. & Fu, J. Encephalopathy in preterm infants: advances in neuroprotection with caffeine. Front. Pediatr. 9, 724161 (2021).","journal-title":"Front. Pediatr."},{"key":"1924_CR65","doi-asserted-by":"publisher","unstructured":"Wang, H. Q. et al. Caffeine inhibits activation of the NLRP3 inflammasome via autophagy to attenuate microglia-mediated neuroinflammation in experimental autoimmune encephalomyelitis. J. Mol. Neurosci. https:\/\/doi.org\/10.1007\/s12031-021-01894-8 (2021).","DOI":"10.1007\/s12031-021-01894-8"},{"key":"1924_CR66","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.7150\/ijbs.34211","volume":"15","author":"W Zhao","year":"2019","unstructured":"Zhao, W., Ma, L., Cai, C. & Gong, X. Caffeine inhibits NLRP3 inflammasome activation by suppressing MAPK\/NF-\u03baB and A2aR signaling in LPS-induced THP-1 macrophages. Int. J. Biol. Sci. 15, 1571\u20131581 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"1924_CR67","doi-asserted-by":"publisher","first-page":"4761081","DOI":"10.1155\/2017\/4761081","volume":"2017","author":"MH Madeira","year":"2017","unstructured":"Madeira, M. H., Boia, R., Ambr\u00f3sio, A. F. & Santiago, A. R. Having a coffee break: the impact of caffeine consumption on microglia-mediated inflammation in neurodegenerative diseases. Mediators Inflamm. 2017, 4761081 (2017).","journal-title":"Mediators Inflamm."},{"key":"1924_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.451","volume":"8","author":"R Boia","year":"2017","unstructured":"Boia, R. et al. Treatment with A(2A) receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage. Cell Death Dis. 8, e3065 (2017).","journal-title":"Cell Death Dis."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01924-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T13:04:25Z","timestamp":1671627865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01924-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,26]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1924"],"URL":"https:\/\/doi.org\/10.1038\/s41390-021-01924-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,26]]},"assertion":[{"value":"7 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patient consent was not required for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}